Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Bexarotene in Cutaneous T-cell Lymphoma
NCT00660231Phase 2Completed
- Sponsor
- University College London
- Start
- Mar 2008
- Primary completion
- Sep 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, bexarotene in cutaneous T-cell lymphoma (CTCL), sponsored by University College London. Started Mar 2008; status: completed.
02
Drugs
gemcitabinebexarotene
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT00660231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660231.